Process laboratory biosensor Octet® FAB2G

process laboratory biosensor
process laboratory biosensor
Add to favorites
Compare this product
 

Characteristics

Applications
process

Description

Perform kinetic screening, off-rate ranking, and epitope binning of Fabs in crude or partially purified samples Easy capture of human Fab or IgG for kinetic analysis of binding to target antigen or Fc receptors (Kon, Koff, KD) Rapid quantitation of all subclasses of human Fab, F(ab′)2 and IgG No recognition towards human kappa or lambda light chains Improved Fab capture affinity, baseline stability, and regeneration over original FAB biosensors Octet® FAB2G biosensors come pre-immobilized with a high-affinity ligand that is specific for the CH1 region of Human IgG. In conjunction with the Octet Systems, FAB2G biosensors provide a rapid and label-free solution for analysis of Fab fragments or full-length human IgG for lead identification and optimization, epitope binning, cell line screening, process development, and QC applications. The anti-human CH1 ligand has no recognition towards free light chains or cross-reactivity with murine or bovine IgG. This high level of specificity enables direct analysis of IgG or Fab analytes directly from complex samples such as cell culture supernatants, lysates, or partially purified samples, offering a time-saving alternative to traditional analytical methods.

Catalogs

No catalogs are available for this product.

See all of Sartorius Group‘s catalogs

Exhibitions

Meet this supplier at the following exhibition(s):

ANALYTICA 2024
ANALYTICA 2024

9-12 Apr 2024 München (Germany) Hall A3.308 - Stand Vide

  • More information
    CMEF 2024
    CMEF 2024

    11-14 Apr 2024 Shanghai (China) Hall vide - Stand vide

  • More information
    *Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.